Literature DB >> 11695675

Synthesis of Streptococcus pneumoniae type 3 neoglycoproteins varying in oligosaccharide chain length, loading and carrier protein.

D J Lefeber1, J P Kamerling, J F Vliegenthart.   

Abstract

The preparation is described of a range of neoglycoproteins containing synthesised fragments of the capsular polysaccharide of Streptococcus pneumoniae type 3, that is beta-D-GlcpA-(1-->4)-beta-D-Glcp-(1-->O)-(CH2)3NH2 (1), beta-D-Glcp-(1-->3)-beta-D-GlcpA-(1-->4)-beta-D-Glcp-(1-->O)-(CH2)3NH2 (2), and beta-D-GlcpA-(1-->4)-beta-D-Glcp-(1-->3)-beta-D-GlcpA-(1-->4)-beta-D-Glcp-(1-->O)-(CH4)NH2 (3). A blockwise approach was developed for the synthesis of the protected carbohydrate chains, in which the carboxylic groups were introduced prior to deprotection by selective oxidation of HO-6 in the presence of HO-4 by using TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy radical). After deprotection, the 3-aminopropyl spacer of the fragments was elongated with diethyl squarate (3,4-diethoxy-3-cyclobutene-1,2-dione) and the elongated oligosaccharides were conjugated to CRM197 (cross-reacting material of diphtheria toxin), KLH (keyhole limpet hemocyanin) or TT (tetanus toxoid). The resulting neoglycoconjugates varied in oligosaccharide chain length, oligosaccharide loading and protein carrier. These well-defined conjugates are ideal probes for evaluating the influence of the different structural parameters in immunological tests.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695675     DOI: 10.1002/1521-3765(20011015)7:20<4411::aid-chem4411>3.0.co;2-t

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Determination of the glycation sites of Bacillus anthracis neoglycoconjugate vaccine by MALDI-TOF/TOF-CID-MS/MS and LC-ESI-QqTOF-tandem mass spectrometry.

Authors:  Farid Jahouh; Shu-jie Hou; Pavol Kováč; Joseph H Banoub
Journal:  J Mass Spectrom       Date:  2011-10       Impact factor: 1.982

2.  Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Authors:  Peng Xu; Meagan Kelly; Willie F Vann; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Chembiochem       Date:  2017-03-23       Impact factor: 3.164

3.  Facile chemoenzymatic synthesis of biotinylated heparosan hexasaccharide.

Authors:  Baolin Wu; Na Wei; Vireak Thon; Mohui Wei; Zaikuan Yu; Yongmei Xu; Xi Chen; Jian Liu; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-05-14       Impact factor: 3.876

4.  Regioselective Benzylation of 2-Deoxy-2-Aminosugars Using Crown Ethers: Application to a Shortened Synthesis of Hyaluronic Acid Oligomers.

Authors:  Chinmoy Mukherjee; Lin Liu; Nicola L B Pohl
Journal:  Adv Synth Catal       Date:  2014-07-07       Impact factor: 5.837

5.  Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.

Authors:  Wenjing Shang; Zhongying Xiao; Zaikuan Yu; Na Wei; Guohui Zhao; Qing Zhang; Mohui Wei; Xuan Wang; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-03-12       Impact factor: 3.876

6.  Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.

Authors:  Dirk J Lefeber; Barry Benaissa-Trouw; Johannes F G Vliegenthart; Johannis P Kamerling; Wouter T M Jansen; Kees Kraaijeveld; Harm Snippe
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  Preparation of glycoconjugates by dialkyl squarate chemistry revisited.

Authors:  Shu-Jie Hou; Rina Saksena; Pavol Kovác
Journal:  Carbohydr Res       Date:  2007-10-26       Impact factor: 2.104

8.  Automated glycan assembly of a S. pneumoniae serotype 3 CPS antigen.

Authors:  Markus W Weishaupt; Stefan Matthies; Mattan Hurevich; Claney L Pereira; Heung Sik Hahm; Peter H Seeberger
Journal:  Beilstein J Org Chem       Date:  2016-07-12       Impact factor: 2.883

9.  Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide.

Authors:  Peter H Seeberger; Claney L Pereira; Subramanian Govindan
Journal:  Beilstein J Org Chem       Date:  2017-01-25       Impact factor: 2.883

10.  Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites.

Authors:  Uwe Möginger; Anja Resemann; Christopher E Martin; Sharavathi Parameswarappa; Subramanian Govindan; Eike-Christian Wamhoff; Felix Broecker; Detlev Suckau; Claney Lebev Pereira; Chakkumkal Anish; Peter H Seeberger; Daniel Kolarich
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.